Table 2:
Open in new tab

BOS classification according to the ISHLT statement of 2003 [12]

BOS 0FEV1 > 90% of baseline and FEV25–75 > 75% of baseline
BOS 0pFEV1 81–90% of baseline and/or FEV25–75 ≤ 75% of baseline
BOS 1FEV1 66–80% of baseline
BOS 2FEV1 51–65% of baseline
BOS 3FEV1 ≤ 50% of baseline
BOS 0FEV1 > 90% of baseline and FEV25–75 > 75% of baseline
BOS 0pFEV1 81–90% of baseline and/or FEV25–75 ≤ 75% of baseline
BOS 1FEV1 66–80% of baseline
BOS 2FEV1 51–65% of baseline
BOS 3FEV1 ≤ 50% of baseline

BOS grades 2 or 3 post-transplantation were considered for the analysis.

Table 2:
Open in new tab

BOS classification according to the ISHLT statement of 2003 [12]

BOS 0FEV1 > 90% of baseline and FEV25–75 > 75% of baseline
BOS 0pFEV1 81–90% of baseline and/or FEV25–75 ≤ 75% of baseline
BOS 1FEV1 66–80% of baseline
BOS 2FEV1 51–65% of baseline
BOS 3FEV1 ≤ 50% of baseline
BOS 0FEV1 > 90% of baseline and FEV25–75 > 75% of baseline
BOS 0pFEV1 81–90% of baseline and/or FEV25–75 ≤ 75% of baseline
BOS 1FEV1 66–80% of baseline
BOS 2FEV1 51–65% of baseline
BOS 3FEV1 ≤ 50% of baseline

BOS grades 2 or 3 post-transplantation were considered for the analysis.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close